131 related articles for article (PubMed ID: 35671592)
21. Evaluation of four affibody-based near-infrared fluorescent probes for optical imaging of epidermal growth factor receptor positive tumors.
Qi S; Miao Z; Liu H; Xu Y; Feng Y; Cheng Z
Bioconjug Chem; 2012 Jun; 23(6):1149-56. PubMed ID: 22621238
[TBL] [Abstract][Full Text] [Related]
22. Discovery of a highly efficient nitroaryl group for detection of nitroreductase and imaging of hypoxic tumor cells.
Wang S; Wu X; Zhang Y; Zhang D; Xie B; Pan Z; Ouyang K; Peng T
Org Biomol Chem; 2021 Apr; 19(15):3469-3478. PubMed ID: 33899896
[TBL] [Abstract][Full Text] [Related]
23. Estrogen receptor-beta activated apoptosis in benign hyperplasia and cancer of the prostate is androgen independent and TNFalpha mediated.
McPherson SJ; Hussain S; Balanathan P; Hedwards SL; Niranjan B; Grant M; Chandrasiri UP; Toivanen R; Wang Y; Taylor RA; Risbridger GP
Proc Natl Acad Sci U S A; 2010 Feb; 107(7):3123-8. PubMed ID: 20133657
[TBL] [Abstract][Full Text] [Related]
24. Estrogen receptor β exerts tumor suppressive effects in prostate cancer through repression of androgen receptor activity.
Chaurasiya S; Widmann S; Botero C; Lin CY; Gustafsson JÅ; Strom AM
PLoS One; 2020; 15(5):e0226057. PubMed ID: 32413024
[TBL] [Abstract][Full Text] [Related]
25. Resveratrol inhibits hypoxia-inducible factor-1α-mediated androgen receptor signaling and represses tumor progression in castration-resistant prostate cancer.
Mitani T; Harada N; Tanimori S; Nakano Y; Inui H; Yamaji R
J Nutr Sci Vitaminol (Tokyo); 2014; 60(4):276-82. PubMed ID: 25297617
[TBL] [Abstract][Full Text] [Related]
26. Modulation of Mitochondrial ERβ Expression Inhibits Triple-Negative Breast Cancer Tumor Progression by Activating Mitochondrial Function.
Song IS; Jeong YJ; Jeong SH; Kim JE; Han J; Kim TH; Jang SW
Cell Physiol Biochem; 2019; 52(3):468-485. PubMed ID: 30873822
[TBL] [Abstract][Full Text] [Related]
27. Osteoblasts promote castration-resistant prostate cancer by altering intratumoral steroidogenesis.
Hagberg Thulin M; Nilsson ME; Thulin P; Céraline J; Ohlsson C; Damber JE; Welén K
Mol Cell Endocrinol; 2016 Feb; 422():182-191. PubMed ID: 26586211
[TBL] [Abstract][Full Text] [Related]
28. Oestrogen receptor beta is required for androgen-stimulated proliferation of LNCaP prostate cancer cells.
Maggiolini M; Recchia AG; Carpino A; Vivacqua A; Fasanella G; Rago V; Pezzi V; Briand PA; Picard D; Andò S
J Mol Endocrinol; 2004 Jun; 32(3):777-91. PubMed ID: 15171712
[TBL] [Abstract][Full Text] [Related]
29. The relevance of estrogen receptor-beta expression to the antiproliferative effects observed with histone deacetylase inhibitors and phytoestrogens in prostate cancer treatment.
Stettner M; Kaulfuss S; Burfeind P; Schweyer S; Strauss A; Ringert RH; Thelen P
Mol Cancer Ther; 2007 Oct; 6(10):2626-33. PubMed ID: 17913855
[TBL] [Abstract][Full Text] [Related]
30. Development of a hypoxia-activated red-emission fluorescent probe for in vivo tumor microenvironment imaging and anti-tumor therapy.
Jin C; Wu P; Tu M; Zhu HL; Li Z
Mikrochim Acta; 2024 Mar; 191(4):217. PubMed ID: 38519619
[TBL] [Abstract][Full Text] [Related]
31. Hypoxia-responsive AIEgens for precise disease theranostics.
Liu D; Liang M; Fan A; Bing W; Qi J
Luminescence; 2024 Jan; 39(1):e4659. PubMed ID: 38286609
[TBL] [Abstract][Full Text] [Related]
32. Endothelial NOS, estrogen receptor beta, and HIFs cooperate in the activation of a prognostic transcriptional pattern in aggressive human prostate cancer.
Nanni S; Benvenuti V; Grasselli A; Priolo C; Aiello A; Mattiussi S; Colussi C; Lirangi V; Illi B; D'Eletto M; Cianciulli AM; Gallucci M; De Carli P; Sentinelli S; Mottolese M; Carlini P; Strigari L; Finn S; Mueller E; Arcangeli G; Gaetano C; Capogrossi MC; Donnorso RP; Bacchetti S; Sacchi A; Pontecorvi A; Loda M; Farsetti A
J Clin Invest; 2009 May; 119(5):1093-108. PubMed ID: 19363294
[TBL] [Abstract][Full Text] [Related]
33. Estrogen Receptor Signaling Pathways Involved in Invasion and Colony Formation of Androgen-Independent Prostate Cancer Cells PC-3.
Lombardi APG; Cavalheiro RP; Porto CS; Vicente CM
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33503805
[TBL] [Abstract][Full Text] [Related]
34. Overexpression of ERβ is sufficient to inhibit hypoxia-inducible factor-1 transactivation.
Park C; Lee Y
Biochem Biophys Res Commun; 2014 Jul; 450(1):261-6. PubMed ID: 24938129
[TBL] [Abstract][Full Text] [Related]
35. Near-infrared off-on fluorescence probe activated by NTR for in vivo hypoxia imaging.
Zheng J; Shen Y; Xu Z; Yuan Z; He Y; Wei C; Er M; Yin J; Chen H
Biosens Bioelectron; 2018 Nov; 119():141-148. PubMed ID: 30125874
[TBL] [Abstract][Full Text] [Related]
36. Design, synthesis and application of near-infrared fluorescence probe IR-780-Crizotinib in detection of ALK positive tumors.
Wang J; Sun C; Ji M; Wang B; Wang P; Zhou G; Dong B; Du W; Huang L; Wang H; Ren L
Protein Expr Purif; 2021 Nov; 187():105952. PubMed ID: 34375729
[TBL] [Abstract][Full Text] [Related]
37. Non-Covalently Pre-Assembled High-Performance Near-Infrared Fluorescent Molecular Probes for Cancer Imaging.
Shaw SK; Liu W; Gómez Durán CFA; Schreiber CL; Betancourt Mendiola ML; Zhai C; Roland FM; Padanilam SJ; Smith BD
Chemistry; 2018 Sep; 24(52):13821-13829. PubMed ID: 30022552
[TBL] [Abstract][Full Text] [Related]
38. Human T47D-ERβ breast cancer cells with tetracycline-dependent ERβ expression reflect ERα/ERβ ratios in rat and human breast tissue.
Evers NM; van de Klundert TM; van Aesch YM; Wang S; de Roos WK; Romano A; de Haan LH; Murk AJ; Ederveen AG; Rietjens IM; Groten JP
Toxicol In Vitro; 2013 Sep; 27(6):1753-61. PubMed ID: 23680332
[TBL] [Abstract][Full Text] [Related]
39. Biodegradable and switchable near-infrared fluorescent probes for hypoxia detection.
Srivastava I; Moitra P; Brent KM; Wang K; Pandit S; Altun E; Pan D
Nanomedicine (Lond); 2023 Jul; 18(16):1061-1073. PubMed ID: 37610080
[TBL] [Abstract][Full Text] [Related]
40. γ-Glutamyl transpeptidase-activatable near-infrared nanoassembly for tumor fluorescence imaging-guided photothermal therapy.
Zhou F; Yang S; Zhao C; Liu W; Yao X; Yu H; Sun X; Liu Y
Theranostics; 2021; 11(14):7045-7056. PubMed ID: 34093870
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
